Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil

AIDS Research and Human Retroviruses

Volumn 17, Issue 13, 2001, Pages 1241-1247

  Argolo Ferraro G ^a   Gomes Mello, M A ^a   Sutmoller F ^a   Van Weyenbergh, J ^a   Shindo, N ^a   Galvao Castro B ^a   Bou Habib, D C ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; DEXTRAN SULFATE; UNCLASSIFIED DRUG;

ARTICLE; BRAZIL; CELL FUSION; CONTROLLED STUDY; DRUG MECHANISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SYNCYTIUM; T LYMPHOCYTE; VIROGENESIS; VIRUS CULTURE; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN;

BRAZIL; CELL LINE; DEXTRAN SULFATE; GIANT CELLS; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; RECEPTORS, CCR5; RECEPTORS, CXCR4; SUBSTRATE SPECIFICITY;

EID: 0034814149     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201750461294     Document Type: Article

References (44)

1. HIV-1 nomenclature proposal
2. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy
3. HIV treatment failure: Testing for HIV resistance in clinical practice
4. HIV vaccines - Where are we going?
5. Glimmerings of hope from the bottom of the well
6. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection
7. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression
8. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
9. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
10. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
11. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression
12. Jitters jeopardize AIDS vaccine trials
13. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120
14. HIV-1 attachment: Another look
15. The immunopathogenesis of HIV infection
16. Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype
17. Criptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization
18. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes
19. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals
20. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
21. HIV-1 tropism and co-receptor use
22. Resistance of human immunodeficiency virus type 1 to neutralization by natural anti-sera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites
23. Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses
24. HIV-1 diversity in Brazil: Genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites
25. Molecular epidemiology of HIV-1 in Brazil: High prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil
26. A nationwide effort to systematically monitor HIV-1 diversity in Brazil: Preliminary results
27. Centers for Disease Control and Prevention: 1993 revised classification system and expanded surveillance definition for AIDS among adolescents and adults
28. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
29. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interations with this chemokine receptor
30. Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation
31. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions
32. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions
33. Role of CXCR-4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: Two distinct mechanisms of HIV-1 dual tropism
34. CXCR-4 as a functional coreceptor for human immunodeficiency in macrophages
35. CXCR-4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates
36. A mechanism of resistance to HIV-1 entry: Inefficient interactions of CXCR4 with CD4 and gp120 in macrophages
37. How does HIV cause AIDS?
38. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): Failure to dowregulate CD4 and to interfere with cell-line-tropic HIV-1
39. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strains of human immunodeficiency virus type 1
40. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates
41. Redefinition of tropism of common macrophage-tropic human immunodeficiency virus type 1
42. Isolation and characterization of a syncytium-inducing macrophage/T cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo
43. HIV-1 entry inhibitors: Evading the issue